Tilray | TRLY - Aktuelle Verpflichtungen

Aktienkurs
8.99
Täglich Wechseln
-0.27 -2.92%
Monatlich
-9.83%
Jährlich
1,304.69%
Q2 Prognose
8.92




Aktuelle Verpflichtungen Veränderung Datum
Acasti Pharma USD 1.24M 1.08M 2025-09
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Avita Medical AUD 62.68M 77K 2025-12
Canopy Growth CAD 98.29M 17.19M 2025-12
Cronos Group USD 48.19M 7.12M 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Moderna USD 1.99B 306M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Revvity USD 1.33B 108.5M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12